← Open Payments lookup

KAREN BROWN: Open Payments

NPI 1558342956 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,873 in 89 payments from 18 companies in 2025. Trend: 2023 $1,267 · 2024 $1,708 · 2025 $1,873

Food & beverage: $1,854Education: $19
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$280
ABBVIE INC.14$246
Otsuka America Pharmaceutical, Inc.11$202
Teva Pharmaceuticals USA, Inc.10$190
Neurocrine BioSciences, Inc.7$178
Corium, LLC5$147
Alkermes, Inc.5$109
Takeda Pharmaceuticals U.S.A., Inc.3$65
Axsome Therapeutics, Inc.3$62
Vanda Pharmaceuticals Inc.3$61

Products named: CAPLYTA, REXULTI, INGREZZA, VRAYLAR, AUSTEDO XR, Azstarys, ARISTADA, DURYSTA.

Industry payments across TX — which companies pay providers there.